Cargando…
Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study
PURPOSE: Erythropoiesis-stimulating agents (ESAs) are often used in treatment of patients with chemotherapy-induced anemia. Many studies have demonstrated an improved hemoglobin (Hb) response when ESA is combined with intravenous iron supplementation and a higher effectiveness of intravenous iron ov...
Autores principales: | Mafodda, Antonino, Giuffrida, D., Prestifilippo, A., Azzarello, D., Giannicola, R., Mare, M., Maisano, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527057/ https://www.ncbi.nlm.nih.gov/pubmed/28391437 http://dx.doi.org/10.1007/s00520-017-3690-z |
Ejemplares similares
-
Comparative Evaluation of Sucrosomial Iron and Iron Oxide Nanoparticles as Oral Supplements in Iron Deficiency Anemia in Piglets
por: Mazgaj, Rafał, et al.
Publicado: (2021) -
Sucrosomial(®) Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency
por: Gómez-Ramírez, Susana, et al.
Publicado: (2023) -
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
por: Riccio, Eleonora, et al.
Publicado: (2020) -
Sucrosomial Iron Supplementation in Anemic Patients with Celiac Disease Not Tolerating Oral Ferrous Sulfate: A Prospective Study
por: Elli, Luca, et al.
Publicado: (2018) -
Sucrosomial(®) Iron: A New Generation Iron for Improving Oral Supplementation
por: Gómez-Ramírez, Susana, et al.
Publicado: (2018)